Old Web
English
Sign In
Acemap
>
Paper
>
Relugolix, A Novel Oral GnRH Receptor Antagonist, versus Leuprolide Depot for Prostate Cancer: The HERO Phase 3 Trial
Relugolix, A Novel Oral GnRH Receptor Antagonist, versus Leuprolide Depot for Prostate Cancer: The HERO Phase 3 Trial
2020
D.E. Spratt
Neal D. Shore
Alberto Bossi
D. van Veenhuyzen
Bryan Selby
Vicky Kang
David P. Dearnaley
Keywords:
Prostate cancer
Medicine
HERO
Pharmacology
Depot
Antagonist
Gnrh receptor
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]